Lung cancer imaging.
暂无分享,去创建一个
[1] Marcos Salganicoff,et al. Benefit of computer-aided detection analysis for the detection of subsolid and solid lung nodules on thin- and thick-section CT. , 2013, AJR. American journal of roentgenology.
[2] Darel E. Heitkamp,et al. ACR appropriateness criteria® hemoptysis. , 2010, Journal of thoracic imaging.
[3] Darel E. Heitkamp,et al. ACR Appropriateness Criteria® acute respiratory illness in immunocompetent patients. , 2011, Journal of thoracic imaging.
[4] D. Naidich,et al. Subsolid pulmonary nodules: imaging evaluation and strategic management , 2012, Current opinion in pulmonary medicine.
[5] Walter J. Coulson,et al. The rate of growth and apparent duration of untreated primary bronchial carcinoma , 1963, Cancer.
[6] P C Goodman,et al. Staging non-small cell lung cancer with whole-body PET. , 1999, Radiology.
[7] E. Patz. Imaging bronchogenic carcinoma. , 2000, Chest.
[8] R. L. Maldonado. The CT angiogram sign. , 1999, Radiology.
[9] Masafumi Okada,et al. Nuclear grading of primary pulmonary adenocarcinomas , 2010, Cancer.
[10] Ali O. Farooqi,et al. Lung cancer associated with cystic airspaces. , 2012, AJR. American journal of roentgenology.
[11] A. Alavi,et al. 18F-FDG PET in characterizing adrenal lesions detected on CT or MRI. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[12] Matthew J Hayat,et al. Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. , 2007, The oncologist.
[13] J. Austin,et al. Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. , 2005, Radiology.
[14] R. Reznek,et al. Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors. , 2001, The Journal of clinical endocrinology and metabolism.
[15] M. Chung,et al. Efficacy of PET/CT in the characterization of solid or partly solid solitary pulmonary nodules. , 2008, Lung cancer.
[16] K. Geisinger,et al. Atypical carcinoid of the lung: radiographic features. , 1986, AJR. American journal of roentgenology.
[17] Tae Jung Kim,et al. Is there a role for FDG PET in the management of lung cancer manifesting predominantly as ground-glass opacity? , 2012, AJR. American journal of roentgenology.
[18] Sumit K. Shah,et al. Computer-aided lung nodule detection in CT: results of large-scale observer test. , 2005, Academic radiology.
[19] B. Taal,et al. The role of I-131-MIBG in the diagnosis and therapy of carcinoids , 2004, European Journal of Nuclear Medicine.
[20] D. Owens,et al. Test Performance of Positron Emission Tomography and Computed Tomography for Mediastinal Staging in Patients with NonSmall-Cell Lung Cancer , 2003, Annals of Internal Medicine.
[21] N. Gupta,et al. Positron emission tomography of lung tumors and mediastinal lymph nodes using [18F]fluorodeoxyglucose , 1994 .
[22] Scott T. Grafton,et al. PET and [18F]-FDG in oncology: a clinical update. , 1996, Nuclear medicine and biology.
[23] K F Hübner,et al. Differentiating benign from malignant lung lesions using "quantitative" parameters of FDG PET images. , 1996, Clinical nuclear medicine.
[24] S. Swisher,et al. Early-stage pulmonary adenocarcinoma (T1N0M0): a clinical, radiological, surgical, and pathological correlation of 104 cases. The MD Anderson Cancer Center Experience , 2013, Modern Pathology.
[25] M. Kosty,et al. Large cell/neuroendocrine carcinoma. , 2010, Lung cancer.
[26] Huan Wang,et al. Multilevel binomial logistic prediction model for malignant pulmonary nodules based on texture features of CT image. , 2010, European journal of radiology.
[27] J. Gurney. Determining the likelihood of malignancy in solitary pulmonary nodules with Bayesian analysis. Part I. Theory. , 1993, Radiology.
[28] S. Bernstein,et al. Solitary pulmonary nodules and masses: a meta-analysis of the diagnostic utility of alternative imaging tests , 2008, European Radiology.
[29] C. A. Good,et al. Calcification in solitary nodules of the lung. , 1957, The American journal of roentgenology, radium therapy, and nuclear medicine.
[30] F. Zaccagna,et al. Whole-tumour CT-perfusion of unresectable lung cancer for the monitoring of anti-angiogenetic chemotherapy effects. , 2013, The British journal of radiology.
[31] S. F. Carbone,et al. MSCT multi-criteria: a novel approach in assessment of mediastinal lymph node metastases in non-small cell lung cancer. , 2011, European journal of radiology.
[32] Myrna C B Godoy,et al. Subsolid pulmonary nodules and the spectrum of peripheral adenocarcinomas of the lung: recommended interim guidelines for assessment and management. , 2009, Radiology.
[33] N. Müller,et al. Neuroendocrine carcinomas of the lung: clinical, radiologic, and pathologic correlation. , 1989, Radiology.
[34] N. Müller,et al. Solitary pulmonary nodule: high-resolution CT and radiologic-pathologic correlation. , 1991, Radiology.
[35] J. Seo,et al. Clinical utility of dual-energy CT in the evaluation of solitary pulmonary nodules: initial experience. , 2008, Radiology.
[36] V. Roggli,et al. Solitary pulmonary nodules: Part I. Morphologic evaluation for differentiation of benign and malignant lesions. , 2000, Radiographics : a review publication of the Radiological Society of North America, Inc.
[37] D. Naidich,et al. Subsolid pulmonary nodule management and lung adenocarcinoma classification: state of the art and future trends. , 2013, Seminars in roentgenology.
[38] Jin Mo Goo,et al. Predictive CT findings of malignancy in ground-glass nodules on thin-section chest CT: the effects on radiologist performance , 2008, European Radiology.
[39] K. Miles,et al. Tumour heterogeneity in non-small cell lung carcinoma assessed by CT texture analysis: a potential marker of survival , 2012, European Radiology.
[40] H. Groen,et al. Preoperative staging of non-small-cell lung cancer with positron-emission tomography. , 2000, The New England journal of medicine.
[41] D. Yankelevitz,et al. Peripheral carcinoid tumor of the lung: CT diagnosis. , 1990, AJR. American journal of roentgenology.
[42] Alexander Schick,et al. Comparison of dual-energy subtraction and electronic bone suppression combined with computer-aided detection on chest radiographs: effect on human observers' performance in nodule detection. , 2013, AJR. American journal of roentgenology.
[43] Diagnosis of regional node metastases in lung cancer with computer-aided 3D measurement of the volume and CT-attenuation values of lymph nodes. , 2013, Academic radiology.
[44] Richard D. White,et al. ACR Appropriateness Criteria® acute chest pain--suspected pulmonary embolism. , 2012, Journal of thoracic imaging.
[45] P M A van Ooijen,et al. Inter- and intrascanner variability of pulmonary nodule volumetry on low-dose 64-row CT: an anthropomorphic phantom study. , 2013, The British journal of radiology.
[46] D. Naidich,et al. Overview and Strategic Management of Subsolid Pulmonary Nodules , 2012, Journal of thoracic imaging.
[47] J R Galvin,et al. Thoracic carcinoids: radiologic-pathologic correlation. , 1999, Radiographics : a review publication of the Radiological Society of North America, Inc.
[48] T. Matsumoto,et al. A preliminary study of discrimination among the components of small pulmonary nodules by MR imaging: correlation between MR images and histologic appearance. , 2000, Radiation medicine.
[49] O. Miettinen,et al. CT screening for lung cancer: frequency and significance of part-solid and nonsolid nodules. , 2002, AJR. American journal of roentgenology.
[50] Y. Shim,et al. Persistent pulmonary nodular ground-glass opacity at thin-section CT: histopathologic comparisons. , 2007, Radiology.
[51] F. Schick,et al. Solitary pulmonary nodules: dynamic contrast-enhanced MR imaging--perfusion differences in malignant and benign lesions. , 2004, Radiology.
[52] S. Matsumoto,et al. Non-small cell lung cancer: whole-body MR examination for M-stage assessment--utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT. , 2008, Radiology.
[53] C. White,et al. Evaluation of the air bronchogram sign on CT in solitary pulmonary lesions. , 1996, Journal of computer assisted tomography.
[54] E. Fishman,et al. Pulmonary hamartoma: CT findings. , 1986, Radiology.
[55] S S Sagel,et al. CT of the pulmonary nodule: a cooperative study. , 1986, Radiology.
[56] J. Herndon,et al. T1 lung cancers: sensitivity of diagnosis with fluorodeoxyglucose PET. , 2002, Radiology.
[57] V. P. Collins,et al. Differentiation of benign and malignant pulmonary nodules by growth rate. , 1962, Radiology.
[58] J. Gurney,et al. Determining the likelihood of malignancy in solitary pulmonary nodules with Bayesian analysis. Part II. Application. , 1993, Radiology.
[59] W. Travis. Lung tumours with neuroendocrine differentiation. , 2009, European journal of cancer.
[60] Hyo Jin Kim,et al. Solitary pulmonary nodular lung adenocarcinoma: correlation of histopathologic scoring and patient survival with imaging biomarkers. , 2012, Radiology.
[61] C. Leidecker,et al. Basic principles and postprocessing techniques of dual-energy CT: illustrated by selected congenital abnormalities of the thorax. , 2009, Journal of thoracic imaging.
[62] Byung-Tae Kim,et al. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging. , 2005, Radiology.
[63] Alfred A Bartolucci,et al. The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer. , 2004, The Annals of thoracic surgery.
[64] Takashi Hirai,et al. Tumor invasiveness as defined by the newly proposed IASLC/ATS/ERS classification has prognostic significance for pathologic stage IA lung adenocarcinoma and can be predicted by radiologic parameters. , 2014, The Journal of thoracic and cardiovascular surgery.
[65] Carlo Catalano,et al. Whole-tumor perfusion CT in patients with advanced lung adenocarcinoma treated with conventional and antiangiogenetic chemotherapy: initial experience. , 2011, Radiology.
[66] Charles A Powell,et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summary. , 2011, Proceedings of the American Thoracic Society.
[67] J. Remy,et al. Perfusion CT allows prediction of therapy response in non-small cell lung cancer treated with conventional and anti-angiogenic chemotherapy , 2013, European Radiology.
[68] C. Reed. Patient versus customer, technology versus touch: where has humanism gone? , 2008, The Annals of thoracic surgery.
[69] T. Mohammed,et al. Assessment of the Solitary Pulmonary Nodule: An Overview , 2013 .
[70] Hong Li,et al. Differentiation of malignant and benign pulmonary nodules with first-pass dual-input perfusion CT , 2013, European Radiology.
[71] H Nakata,et al. Evolution of peripheral lung adenocarcinomas: CT findings correlated with histology and tumor doubling time. , 2000, AJR. American journal of roentgenology.
[72] Denise R. Aberle,et al. Radiologic implications of the 2011 classification of adenocarcinoma of the lung. , 2013, Radiology.
[73] N. Müller,et al. Fleischner Society: glossary of terms for thoracic imaging. , 2008, Radiology.
[74] J. Sunderland,et al. Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. , 1992, Radiology.
[75] H. Libshitz,et al. Roentgenographic evaluation of mediastinal nodes for preoperative assessment in lung cancer. , 1985, Chest.
[76] E. Gunel,et al. Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[77] G. V. von Schulthess,et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. , 2003, The New England journal of medicine.
[78] G. Gladish,et al. Imaging of non-small cell lung cancer of the superior sulcus: part 2: initial staging and assessment of resectability and therapeutic response. , 2008, Radiographics : a review publication of the Radiological Society of North America, Inc.
[79] Jue Zhang,et al. Comparison of MRS and DWI in the diagnosis of prostate cancer based on sextant analysis , 2013, Journal of magnetic resonance imaging : JMRI.
[80] Gilles Chatellier,et al. Software volumetric evaluation of doubling times for differentiating benign versus malignant pulmonary nodules. , 2006, AJR. American journal of roentgenology.
[81] L. Luo,et al. Differentiation of Central Lung Cancer from Atelectasis: Comparison of Diffusion-Weighted MRI with PET/CT , 2013, PloS one.
[82] Jinming Yu,et al. Value of PET/CT versus enhanced CT for locoregional lymph nodes in non-small cell lung cancer. , 2008, Lung cancer.
[83] C. White,et al. Imaging characteristics of lung cancer. , 2011, Seminars in roentgenology.
[84] D K Owens,et al. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. , 2001, JAMA.
[85] S. Matsumoto,et al. Prognostic value of dynamic MR imaging for non‐small‐cell lung cancer patients after chemoradiotherapy , 2005, Journal of magnetic resonance imaging : JMRI.
[86] J. Remy,et al. Lung perfusion with dual-energy multi-detector row CT: can it help recognize ground glass opacities of vascular origin? , 2010, Academic radiology.
[87] C. Moran,et al. Bronchogenic carcinoma: radiologic-pathologic correlation. , 1994, Radiographics : a review publication of the Radiological Society of North America, Inc.
[88] Wei-Chih Shen,et al. Density features of screened lung tumors in low-dose computed tomography. , 2014, Academic radiology.
[89] Roberto Maroldi,et al. Texture analysis of advanced non-small cell lung cancer (NSCLC) on contrast-enhanced computed tomography: prediction of the response to the first-line chemotherapy , 2013, European Radiology.
[90] Lorraine Wilson,et al. Lymph node staging by means of positron emission tomography is less accurate in non-small cell lung cancer patients with enlarged lymph nodes: analysis of 1,145 lymph nodes. , 2008, Lung cancer.
[91] V Kalff,et al. F‐18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma , 2001, Cancer.